TY - JOUR
T1 - Correction to: A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma
T2 - A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma
AU - Veldhuijzen van Zanten, Sophie E. M.
AU - El-Khouly, Fatma E.
AU - Jansen, Marc H. A.
AU - Bakker, Dewi P.
AU - Sanchez Aliaga, Esther
AU - Haasbeek, Cornelis J. A.
AU - Wolf, Nicole I.
AU - Zwaan, C. Michel
AU - Vandertop, W. Peter
AU - van Vuurden, Dannis G.
AU - Kaspers, Gertjan J. L.
PY - 2018/1
Y1 - 2018/1
N2 - In Table 2 of the original publication, there were errors in the baseline scores for the PedsQL TM 3.0 Cancer Module questionnaire, so a corrected version of Table 2 is shown in this erratum. In the subcategories of the PedsQL TM 3.0 Cancer Module questionnaire, nausea and fear of procedure did not score significantly lower after treatment compared to baseline. So, based on the corrected data in Table 2, there was no significant decrease in the total score of the cancer questionnaire, and this statement in the previous manuscript was incorrect
AB - In Table 2 of the original publication, there were errors in the baseline scores for the PedsQL TM 3.0 Cancer Module questionnaire, so a corrected version of Table 2 is shown in this erratum. In the subcategories of the PedsQL TM 3.0 Cancer Module questionnaire, nausea and fear of procedure did not score significantly lower after treatment compared to baseline. So, based on the corrected data in Table 2, there was no significant decrease in the total score of the cancer questionnaire, and this statement in the previous manuscript was incorrect
UR - http://www.scopus.com/inward/record.url?scp=85031936372&partnerID=8YFLogxK
U2 - https://doi.org/10.1007/s11060-017-2636-0
DO - https://doi.org/10.1007/s11060-017-2636-0
M3 - Erratum/Corrigendum
C2 - 29063425
SN - 0167-594X
VL - 136
SP - 219
EP - 220
JO - Journal of Neuro-Oncology
JF - Journal of Neuro-Oncology
IS - 1
ER -